Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.

Name: Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
Author: Tsutani, Yasuhiro

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study. — المؤلف: Tsutani, Yasuhiro — BMC cancer 20190403

المؤلف: Tsutani, Yasuhiro
النشر: BMC cancer 20190403
الوصف: 1231 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Bevacizumab؛ Carcinoma, Non-Small-Cell Lung؛ Cisplatin؛ Female؛ Humans